SCHEMBL31307013

SCHEMBL31307013

Nc1ccc(C2=CCCCC2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.53
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ATR Q13535 1/20 0.41
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
JAK3 P52333 1/20 0.39
TBK1 Q9UHD2 1/20 0.36
PSMB5 P28074 3/20 0.35
PTPN11 Q06124 1/20 0.35
CSF1R P07333 1/20 0.34
FFAR2 O15552 2/20 0.33
MAP3K8 P41279 1/20 0.33
KDR P35968 1/20 0.33
FLT3 P36888 1/20 0.33
PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21988063 1.00 TDP1 (0.53) TDP1CASP3SENP8SENP7SENP6
SCHEMBL3143646 0.79 TDP1 (0.53) TDP1CASP3SENP8SENP7SENP6
SCHEMBL30469661 0.79 TDP1 (0.53) TDP1CASP3SENP8SENP7SENP6
SCHEMBL24366369 0.79 TDP1 (0.53) TDP1CASP3SENP8SENP7SENP6
SCHEMBL18015411 0.79 TDP1 (0.53) TDP1CASP3SENP8SENP7SENP6
SCHEMBL17199629 0.76 TDP1 (0.50) TDP1CASP3SENP8SENP7SENP6
SCHEMBL13490344 0.75 TDP1 (0.56) TDP1CASP3SENP8SENP7SENP6
SCHEMBL2643410 0.72 ACMSD (0.46) TDP1JAK2JAK1JAK3TBK1
SCHEMBL171525 0.72 SIGMAR1 (0.44)
SCHEMBL29936063 0.72 SIGMAR1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004785-A Compounds and compositions for the treatment of diseases associated with STING activity 诺华制药股份有限公司 2025-05-16 CN disclosed
CN-112823036-B Compounds and compositions for the treatment of diseases associated with STING activity 艾福姆德尤股份有限公司 2024-11-08 CN disclosed